Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.42 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | FDPS | P14324 | 10/20 | 0.40 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.40 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2349262 | 0.98 | CES2 (0.45) | CYP4F2CYP4A11CES2FDPSGGPS1 | |
| SCHEMBL2340575 | 0.98 | CES2 (0.45) | CYP4F2CYP4A11CES2FDPSGGPS1 | |
| SCHEMBL2348421 | 0.93 | EPHX1 (0.46) | CES2FDPSGGPS1EPHX1 | |
| SCHEMBL2350082 | 0.93 | EPHX1 (0.46) | CES2FDPSGGPS1EPHX1 | |
| SCHEMBL2343700 | 0.93 | EPHX1 (0.41) | CYP4F2CYP4A11CES2FDPSGGPS1 | |
| SCHEMBL2340944 | 0.93 | CYP4F2 (0.39) | CYP4F2CYP4A11CES2FDPSCES1 | |
| SCHEMBL2345689 | 0.88 | CYP4F2 (0.39) | CYP4F2CYP4A11CES2FDPSCES1 | |
| SCHEMBL2348620 | 0.88 | CES2 (0.48) | CES2FDPSGGPS1CES1EPHX1 | |
| SCHEMBL2344936 | 0.88 | CES2 (0.48) | CES2FDPSGGPS1CES1EPHX1 | |
| SCHEMBL2341017 | 0.88 | CES2 (0.48) | CES2FDPSGGPS1CES1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2078724-B1 | PROCESS FOR PRODUCTION OF DIALKYLTIN DIALKOXIDES | ASAHI CHEMICAL IND (JP) | 2016-11-30 | — | — | EP | disclosed |
| CN-101522697-B | Process for production of dialkyltin dialkoxides | ASAHI KASEI CHEMICALS CORP (JP) | 2013-05-29 | — | — | CN | disclosed |
| US-8008518-B2 | Process for producing dialkyl tin dialkoxides | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-08-30 | — | — | US | disclosed |
| US-20100041908-A1 | PROCESS FOR PRODUCING DIALKYL TIN DIALKOXIDES | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-2078724-A1 | PROCESS FOR PRODUCTION OF DIALKYLTIN DIALKOXIDES | Asahi Kasei Chemicals Corporation (JP) | 2009-07-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041908-A1 | PROCESS FOR PRODUCING DIALKYL TIN DIALKOXIDES | DEK, DDT, DERA | CYP4F2 415/4885CYP4A11 200/4885CES2 717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.